265 related articles for article (PubMed ID: 26121234)
21. Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective?
Chai W; Garrelds IM; Arulmani U; Schoemaker RG; Lamers JM; Danser AH
Br J Pharmacol; 2005 Jul; 145(5):664-71. PubMed ID: 15834444
[TBL] [Abstract][Full Text] [Related]
22. EF domains are sufficient for nongenomic mineralocorticoid receptor actions.
Grossmann C; Freudinger R; Mildenberger S; Husse B; Gekle M
J Biol Chem; 2008 Mar; 283(11):7109-16. PubMed ID: 18184651
[TBL] [Abstract][Full Text] [Related]
23. Finerenone Impedes Aldosterone-dependent Nuclear Import of the Mineralocorticoid Receptor and Prevents Genomic Recruitment of Steroid Receptor Coactivator-1.
Amazit L; Le Billan F; Kolkhof P; Lamribet K; Viengchareun S; Fay MR; Khan JA; Hillisch A; Lombès M; Rafestin-Oblin ME; Fagart J
J Biol Chem; 2015 Sep; 290(36):21876-89. PubMed ID: 26203193
[TBL] [Abstract][Full Text] [Related]
24. Effects of aldosterone and spironolactone on the isolated perfused rat heart.
Moreau D; Chardigny JM; Rochette L
Pharmacology; 1996 Jul; 53(1):28-36. PubMed ID: 8875599
[TBL] [Abstract][Full Text] [Related]
25. Beyond Gap Junction Channel Function: the Expression of Cx43 Contributes to Aldosterone-Induced Mesangial Cell Proliferation via the ERK1/2 and PKC Pathways.
Zhang A; Han Y; Wang B; Li S; Gan W
Cell Physiol Biochem; 2015; 36(3):1210-22. PubMed ID: 26138882
[TBL] [Abstract][Full Text] [Related]
26. Aldosterone-specific activation of cardiomyocyte mineralocorticoid receptor in vivo.
Messaoudi S; Gravez B; Tarjus A; Pelloux V; Ouvrard-Pascaud A; Delcayre C; Samuel J; Launay JM; Sierra-Ramos C; Alvarez de la Rosa D; Clément K; Farman N; Jaisser F
Hypertension; 2013 Feb; 61(2):361-7. PubMed ID: 23297371
[TBL] [Abstract][Full Text] [Related]
27. Mineralocorticoid Receptor Blockade Improves Insulin Sensitivity in the Rat Heart and a Possible Molecular Mechanism.
Wang M; Li Y; Zhou K; Zhang G; Wang Y; Liu T; Zhang Y; Guo A; An Y
Cell Physiol Biochem; 2016; 39(3):860-70. PubMed ID: 27497962
[TBL] [Abstract][Full Text] [Related]
28. Aldosterone receptor antagonists and cardiovascular disease: do we need a change of the guard?
Jewell CW; Watson LE; Mock J; Dostal DE
Cardiovasc Hematol Agents Med Chem; 2006 Apr; 4(2):129-53. PubMed ID: 16611048
[TBL] [Abstract][Full Text] [Related]
29. Aldosterone-induced inflammation in the rat heart : role of oxidative stress.
Sun Y; Zhang J; Lu L; Chen SS; Quinn MT; Weber KT
Am J Pathol; 2002 Nov; 161(5):1773-81. PubMed ID: 12414524
[TBL] [Abstract][Full Text] [Related]
30. Estrogen receptor inhibits mineralocorticoid receptor transcriptional regulatory function.
Barrett Mueller K; Lu Q; Mohammad NN; Luu V; McCurley A; Williams GH; Adler GK; Karas RH; Jaffe IZ
Endocrinology; 2014 Nov; 155(11):4461-72. PubMed ID: 25051445
[TBL] [Abstract][Full Text] [Related]
31. Anatomical location and redistribution of G protein-coupled estrogen receptor-1 during the estrus cycle in mouse kidney and specific binding to estrogens but not aldosterone.
Cheng SB; Dong J; Pang Y; LaRocca J; Hixon M; Thomas P; Filardo EJ
Mol Cell Endocrinol; 2014 Feb; 382(2):950-9. PubMed ID: 24239983
[TBL] [Abstract][Full Text] [Related]
32. The cardioprotective effects of mineralocorticoid receptor antagonists.
van den Berg TN; Rongen GA; Fröhlich GM; Deinum J; Hausenloy DJ; Riksen NP
Pharmacol Ther; 2014 Apr; 142(1):72-87. PubMed ID: 24275323
[TBL] [Abstract][Full Text] [Related]
33. Aldosterone stimulates vascular smooth muscle cell proliferation via big mitogen-activated protein kinase 1 activation.
Ishizawa K; Izawa Y; Ito H; Miki C; Miyata K; Fujita Y; Kanematsu Y; Tsuchiya K; Tamaki T; Nishiyama A; Yoshizumi M
Hypertension; 2005 Oct; 46(4):1046-52. PubMed ID: 16087789
[TBL] [Abstract][Full Text] [Related]
34. Aldosterone Negatively Regulates Nrf2 Activity: An Additional Mechanism Contributing to Oxidative Stress and Vascular Dysfunction by Aldosterone.
Rodrigues D; Costa TJ; Silva JF; Neto JTO; Alves JV; Fedoce AG; Costa RM; Tostes RC
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200377
[TBL] [Abstract][Full Text] [Related]
35. Human mineralocorticoid receptor expression renders cells responsive for nongenotropic aldosterone actions.
Grossmann C; Benesic A; Krug AW; Freudinger R; Mildenberger S; Gassner B; Gekle M
Mol Endocrinol; 2005 Jul; 19(7):1697-710. PubMed ID: 15761031
[TBL] [Abstract][Full Text] [Related]
36. 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Nongenomic effects via the mineralocorticoid receptor.
Ruhs S; Nolze A; Hübschmann R; Grossmann C
J Endocrinol; 2017 Jul; 234(1):T107-T124. PubMed ID: 28348113
[TBL] [Abstract][Full Text] [Related]
37. Aldosterone increases cardiac vagal tone via G protein-coupled oestrogen receptor activation.
Brailoiu GC; Benamar K; Arterburn JB; Gao E; Rabinowitz JE; Koch WJ; Brailoiu E
J Physiol; 2013 Sep; 591(17):4223-35. PubMed ID: 23878371
[TBL] [Abstract][Full Text] [Related]
38. Delineating the receptor mechanisms underlying the rapid vascular contractile effects of aldosterone and estradiol.
Gros R; Ding Q; Davis M; Shaikh R; Liu B; Chorazyczewski J; Pickering JG; Feldman RD
Can J Physiol Pharmacol; 2011 Sep; 89(9):655-63. PubMed ID: 21854125
[TBL] [Abstract][Full Text] [Related]
39. Aldosterone regulates vascular gene transcription via oxidative stress-dependent and -independent pathways.
Newfell BG; Iyer LK; Mohammad NN; McGraw AP; Ehsan A; Rosano G; Huang PL; Mendelsohn ME; Jaffe IZ
Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1871-80. PubMed ID: 21617142
[TBL] [Abstract][Full Text] [Related]
40. Preconditioning actions of aldosterone through p38 signaling modulation in isolated rat hearts.
Yoshino T; Nagoshi T; Anzawa R; Kashiwagi Y; Ito K; Katoh D; Fujisaki M; Kayama Y; Date T; Hongo K; Yoshimura M
J Endocrinol; 2014 Aug; 222(2):289-99. PubMed ID: 24895416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
